Use of "iSuite" During CMR-guided Electrophysiological Procedures

Sponsor
Academisch Ziekenhuis Maastricht (Other)
Overall Status
Recruiting
CT.gov ID
NCT04727645
Collaborator
(none)
100
1
22.9
4.4

Study Details

Study Description

Brief Summary

The perpuse of this study is to investigate the feasibility of the Philips interventional MRI suite "iSuite" to create an electroanatomical map of the heart based on which the real-time location of the catheters can be correctly and reliably visualized during CMR-guided electrophysiological procedure (CMR-EP).

Condition or Disease Intervention/Treatment Phase
  • Other: Philips interventional MRI suite (Philips Healthcare, Best, the Netherlands)

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Use of Philips "iSuite" Electroanatomical Mapping System in Addition to Standard CMR-guided Electrophysiological Procedures
Actual Study Start Date :
Jan 4, 2021
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Outcome Measures

Primary Outcome Measures

  1. The feasibility of iSuite to create an electroanatomical map (EAM) of the heart during CMR-EP [Periprocedural]

    To establish whether the visualization by iSuite is correct we will compare the location visualized by the EAM with the reference images as produced by the default cine MRI sequences at the target ablation location just prior to the RF ablation. The definition of correct visualization is: good agreement between the two modalities (EAM and cine MRI) based on visual assessment of the treating electrophysiologist and the supervising CMR expert. When no consensus is reached than the visualization is coded 'incorrect'. This outcome will be dichotomized and coded as 'correct visualization' or 'incorrect visualization'. This categorical variable will be expressed as counts and proportion with 95% confidence interval (CI).

Secondary Outcome Measures

  1. Procedural success as measured by electrical and anatomical confirmation of a complete ablation lesion at the end of the procedure: [Periprocedural]

    Anatomical confirmation of a complete ablation lesion is defined as a continuous line of high signal intensity at the target location on the edema and fibrosis sequences of the CMR at the end of the procedure. This anatomical confirmation will be judged by the CMR expert that is present during the procedure and thus will not be blinded to the EP results. Procedural success and procedural complications will be reported as count and proportion with 95% CI.

  2. Procedural time [Periprocedural]

    To investigate the procedure-by-procedure change in procedural times and total amount of CMR images needed until application of the first ablation lesion

  3. Complication rate [Periprocedural]

    To investigate the complication rate of CMR-EP with the integration of iSuite.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Already scheduled by the treating electrophysiologist for CMR-EP as standard care for the treatment of a cardiac arrhythmia.

  • Minimum age of 18 years old.

  • Written informed consent

Exclusion Criteria:
  • Participation in another investigational study that has not reached its primary endpoint.

  • Contraindication for MRI such as: metallic implant, body weight > 130 kg, pregnancy, breast feeding women, known severe allergy to gadolineum contrast agents, renal failure with eGFR ≤ 30 mL/min/1,73m2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maastricht UMC+ Maastricht Limburg Netherlands 6202 AZ

Sponsors and Collaborators

  • Academisch Ziekenhuis Maastricht

Investigators

  • Principal Investigator: S.M. Chaldoupi, Maastricht UMC+
  • Principal Investigator: Casper Mihl, Maastricht UMC+
  • Study Chair: J.E Wildberger, Prof. Dr, Maastricht UMC+

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
S.M. Chaldoupi, MD, PhD, Academisch Ziekenhuis Maastricht
ClinicalTrials.gov Identifier:
NCT04727645
Other Study ID Numbers:
  • NL74812.068.20
  • METC20-064
First Posted:
Jan 27, 2021
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by S.M. Chaldoupi, MD, PhD, Academisch Ziekenhuis Maastricht
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2021